Bisphosphonates Induce the Osteogenic Gene Expression in Co-cultured Human Endothelial and Mesenchymal Stem Cells

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2013 Dec 31

PMID 24373581

Citations 13

Authors

Viviana Ribeiro

Monica Garcia

Raquel Oliveira

Pedro S Gomes

Bruno Colaco

Maria Helena Fernandes

Affiliations

Soon will be listed here.

Abstract

Bisphosphonates (BPs) are known to affect bone homeostasis and also to have anti-angiogenic properties. Because of the intimate relationship between angiogenesis and osteogenesis, this study analysed the effects of Alendronate (AL) and Zoledronate (ZL) in the expression of endothelial and osteogenic genes on interacting endothelial and mesenchymal stem cells, an issue that was not previously addressed. Alendronate and ZL, 10(-12) -10(-6) M, were evaluated in a direct co-culture system of human dermal microvascular endothelial cells (HDMEC) and human bone marrow mesenchymal stem cells (HMSC), over a period of 14 days. Experiments with the respective monocultures were run in parallel. Alendronate and ZL caused an initial dose-dependent stimulation in the cell proliferation in the monocultures and co-cultures, and did not interfere with their cellular organization. In HDMEC monocultures, the expression of the endothelial genes CD31, VE-cadherin and VEGFR2 was down-regulated by AL and ZL. In HMSC monocultures, the BPs inhibited VEGF expression, but up-regulated the expression of the osteogenic genes alkaline phosphatase (ALP), bone morphogenic protein-2 (BMP-2) and osteocalcin (OC) and, to a greater extent, osteoprotegerin (OPG), a negative regulator of the osteoclastic differentiation, and increased ALP activity. In co-cultured HDMEC/HMSC, AL and ZL decreased the expression of endothelial genes but elicited an earlier and sustained overexpression of ALP, BMP-2, OC and OPG, compared with the monocultured cells; they also induced ALP activity. This study showed for the first time that AL and ZL greatly induced the osteogenic gene expression on interacting endothelial and mesenchymal stem cells.

Citing Articles

Does the use of bisphosphonates during pregnancy affect fetal outcomes? A systematic review.

de Campos W, Araujo R, Teixeira V, Gomes P, Lemos C Eur J Clin Pharmacol. 2024; 80(8):1121-1132.

PMID: 38691138 DOI: 10.1007/s00228-024-03693-7.

Bone Grafts in Dental Medicine: An Overview of Autografts, Allografts and Synthetic Materials.

Ferraz M Materials (Basel). 2023; 16(11).

PMID: 37297251 PMC: 10254799. DOI: 10.3390/ma16114117.

ABCB5 mesenchymal stromal cells therapy protects from hypoxia by restoring Ca homeostasis in vitro and in vivo.

Yan K, Zheng J, Kluth M, Li L, Ganss C, Yard B Stem Cell Res Ther. 2023; 14(1):24.

PMID: 36759868 PMC: 9912525. DOI: 10.1186/s13287-022-03228-w.

Exosomes from Microvascular Endothelial Cells under Mechanical Unloading Inhibit Osteogenic Differentiation via miR-92b-3p/ELK4 Axis.

Zhang X, Zhang L, Xu L, Li G, Wang K, Xue T J Pers Med. 2022; 12(12).

PMID: 36556251 PMC: 9785449. DOI: 10.3390/jpm12122030.

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.

Lu J, Hu D, Ma C, Shuai B Front Pharmacol. 2022; 13:938447.

PMID: 35774616 PMC: 9237325. DOI: 10.3389/fphar.2022.938447.

References

Pedersen T, Blois A, Xue Y, Xing Z, Cottler-Fox M, Fristad I . Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells. J Tissue Eng. 2012; 3(1):2041731412443236. PMC: 3324846. DOI: 10.1177/2041731412443236. View

Yamada J, Tsuno N, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M . Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation. J Surg Res. 2008; 151(1):115-20. DOI: 10.1016/j.jss.2008.01.031. View

Sarasquete M, Gonzalez M, San Miguel J, Garcia-Sanz R . Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis. 2009; 15(6):382-7. DOI: 10.1111/j.1601-0825.2009.01568.x. View

Russell R, Watts N, Ebetino F, Rogers M . Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008; 19(6):733-59. DOI: 10.1007/s00198-007-0540-8. View

Guillotin B, Bareille R, Bourget C, Bordenave L, Amedee J . Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone. 2008; 42(6):1080-91. DOI: 10.1016/j.bone.2008.01.025. View

Kimura M, Miyazawa K, Tabuchi M, Maeda H, Kameyama Y, Goto S . Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin-deficient mice. Calcif Tissue Int. 2008; 82(2):137-47. DOI: 10.1007/s00223-007-9097-y. View

Ziebart T, Pabst A, Klein M, Kammerer P, Gauss L, Brullmann D . Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig. 2009; 15(1):105-11. DOI: 10.1007/s00784-009-0365-2. View

Gerber H, Vu T, Ryan A, Kowalski J, Werb Z, Ferrara N . VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999; 5(6):623-8. DOI: 10.1038/9467. View

Cremers S, Papapoulos S . Pharmacology of bisphosphonates. Bone. 2011; 49(1):42-9. DOI: 10.1016/j.bone.2011.01.014. View

10.

Visconti R, Richardson C, Sato T . Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A. 2002; 99(12):8219-24. PMC: 123048. DOI: 10.1073/pnas.122109599. View

11.

Aguirre A, Planell J, Engel E . Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun. 2010; 400(2):284-91. DOI: 10.1016/j.bbrc.2010.08.073. View

12.

Xue Y, Xing Z, Hellem S, Arvidson K, Mustafa K . Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online. 2009; 8:34. PMC: 2784771. DOI: 10.1186/1475-925X-8-34. View

13.

Scheper M, Badros A, Salama A, Warburton G, Cullen K, Weikel D . A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer. 2009; 17(12):1553-7. DOI: 10.1007/s00520-009-0710-7. View

14.

Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R . Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol. 2002; 282(4):C775-85. DOI: 10.1152/ajpcell.00310.2001. View

15.

Savion N, Pri-Chen S, Pitaru S . Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor. Bone. 2000; 27(6):777-83. DOI: 10.1016/s8756-3282(00)00389-6. View

16.

Skerjanec A, Berenson J, Hsu C, Major P, Miller Jr W, Ravera C . The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. J Clin Pharmacol. 2003; 43(2):154-62. DOI: 10.1177/0091270002239824. View

17.

Michailidou M, Brown H, Lefley D, Evans A, Cross S, Coleman R . Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel?. J Vasc Res. 2010; 47(6):481-93. DOI: 10.1159/000313876. View

18.

Tsai S, Huang P, Chang W, Tsai H, Lin C, Leu H . Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cells. PLoS One. 2012; 7(7):e41065. PMC: 3405104. DOI: 10.1371/journal.pone.0041065. View

19.

Xue Y, Xing Z, Bolstad A, Van Dyke T, Mustafa K . Co-culture of human bone marrow stromal cells with endothelial cells alters gene expression profiles. Int J Artif Organs. 2013; 36(9):650-62. PMC: 4022041. DOI: 10.5301/ijao.5000229. View

20.

Panzavolta S, Torricelli P, Bracci B, Fini M, Bigi A . Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells. J Inorg Biochem. 2008; 103(1):101-6. DOI: 10.1016/j.jinorgbio.2008.09.012. View